USPTO trademark

CYLEMBIO

RegisteredUSPTOWord markClass 5

"CYLEMBIO" is a word mark owned by IO Biotech ApS, filed at the USPTO on September 20, 2023. It is registered and covers class 5 (Pharmaceuticals).

View IO Biotech ApS portfolio Get this data via the API

Data current as of February 25, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since February 25, 2025
Filed: September 20, 2023
Registered: February 25, 2025
Expires: Not recorded
Application no.: 79382512
Registration no.: 7699741
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns CYLEMBIO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

IO Biotech ApS

Denmark

16 trademarks in the portfolioView company

Representative

Bryce J. Maynard

Buchanan Ingersoll & Rooney PC

Goods and services

What the mark covers

The products and services CYLEMBIO is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; pharmaceutical drugs and pharmaceutical substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines

History

What has happened so far

Steps recorded by the USPTO, newest first.

October 3, 2025Final decision transaction processed by ib
September 11, 2025Final disposition notice sent to ib
September 11, 2025Final disposition processed
May 25, 2025Final disposition notice created, to be sent to ib
April 19, 2025Notification of possible opposition - processed by ib
March 31, 2025Notification of possible opposition sent to ib
March 31, 2025Notification of possible opposition created, to be sent to ib
February 25, 2025Notice of registration confirmation emailed
February 25, 2025Registered-principal register
January 7, 2025Official gazette publication confirmation e-mailed

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About CYLEMBIO

Who owns the trademark "CYLEMBIO"?

The USPTO trademark "CYLEMBIO" (application 79382512) is owned by IO Biotech ApS.

What is the status of "CYLEMBIO"?

Its status at the USPTO is: registered.

When was "CYLEMBIO" registered?

It was registered on February 25, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CYLEMBIO and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2b32-6b77-7458-8ac1-69b5ccac07cb
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2b32-6b77-7458-8ac1-69b5ccac07cb",
  "object": "trademark",
  "mark_text": "CYLEMBIO",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "79382512",
  "filing_date": "2023-09-20",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "IO Biotech ApS",
      "entity_id": "ent_019ebb85-2fc9-7070-9c75-30bb8e228650"
    }
  ]
}